Correction to: Nature Protocols https://doi.org/10.1038/s41596-023-00807-w, published online 27 February 2023.

In the version of the article initially published, the Competing Interests section did not include “X.J.Z. serves on the Board of Directors and has an executive leadership position at EarlyDiagnostics. C.-C.L. and T.-Y.K. are employees of EarlyDiagnostics. X.J.Z. and W.L. are stockholders of EarlyDiagnostics. S.L., C.-C.L. have stock options with EarlyDiagnostics. W.L. is a consultant for EarlyDiagnostics. X.J.Z., S.L. and W.L. are inventors on a patent application submitted by the Regents of the University of California and licensed to EarlyDiagnostics (patent no. US20210125683A1).” This has been updated in the HTML and PDF versions of the article.